Guertin J, LeLorier J, Durand M, Gow R, Holbrook A, Levine M. IMPACT OF A RESTRICTIVE DRUG ACCESS PROGRAM ON THE RISK OF CARDIOVASCULAR ENCOUNTERS IN CHILDREN EXPOSED TO ADHD MEDICATIONS. J Popl Ther Clin Pharmacol. 2018;21(3). Accessed November 19, 2024. https://mail.jptcp.com/index.php/jptcp/article/view/302